Iontophoretic Trans-Dermal Drug Delivery Through Sweat Glands by Ter-Antonyan, Vardan
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
5-10-2005
Iontophoretic Trans-Dermal Drug Delivery
Through Sweat Glands
Vardan Ter-Antonyan
University of South Florida
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the American Studies Commons
This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate
Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact scholarcommons@usf.edu.
Scholar Commons Citation
Ter-Antonyan, Vardan, "Iontophoretic Trans-Dermal Drug Delivery Through Sweat Glands" (2005). Graduate Theses and Dissertations.
https://scholarcommons.usf.edu/etd/883
Iontophoretic Trans-Dermal Drug Delivery Through Sweat Glands 
 
 
 
 
by 
 
 
 
 
Vardan Ter-Antonyan  
 
 
 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
      Master of Science  
Department of Physics  
College of Arts and Sciences  
University of South Florida  
 
 
 
 
 
 
Major Professor:  Wei Chen, Ph.D. 
Myung Kim, Ph.D. 
Garrett Matthews, Ph.D. 
 
 
 
Date of Approval: 
May 10, 2005 
 
 
 
 
Keywords: liquid chromatography, human skin, skin conductance, benadryl,  
diphenhydramine hydrochloride   
 
© Copyright 2005, Vardan Ter-Antonyan 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgments 
 I would like to thank my supervisor Prof. Wei Chen (Ph.D.), for all his guidence, 
leadership, discussions, and support, without which it would be impossible to complete the 
thesis. Almost all the fundamental ideas in this work belong to Prof. Wei Chen. 
Also I would like to thank Prof. Heidi Kay (Ph.D.) from the Department of Public Health at 
USF for her help in analyzing the data and doing all the tests, she also gave me lots of 
valuable advice and provided very friendly environment in which the learning process was 
very pleasurable. Also I would like to thank Prof. Edward Turos (Ph.D.) from the 
Department of Chemistry at USF for his advice on the chemistry of Diphenhydramine 
Hydrochloride. Also I would like to thank Dr. Feiran Huang (Ph.D.) for his programming 
work.  
 
Table of Contents 
 
List of Figures   ii 
 
Abstract   iii 
 
Chapter 1 Introduction 1 
 
Chapter 2 Iontophoresis and Contemporary Iontophoretic Methods 4 
 
Chapter 3 Human Skin 7 
 
Chapter 4 Method  11 
 
Chapter 5 Experimental Set-up for Skin Conductance Experiments 13 
  
Chapter 6 Skin Conductance Studies 17 
 
Chapter 7 Results of the Skin Conductance Studies 21 
 
Chapter 8 High Performance Liquid Chromatograph (HPLC) as a Separator 25 
          8.1 Instrumentation 28  
          8.2 HPLC Analysis 28 
 
Chapter 9 Results of the Drug Delivery Experiment 30 
          9.1 Results  37 
          9.2 Conclusion  38 
 
References   39 
 
 
 
 
 
 
 
                     
                           
                                  i 
List of Figures 
 
 
Figure 1 A contemporary iontophoretic drug delivery system 6 
 
Figure 2 Human Skin 10 
 
Figure 3 Schematic diagram of circuit and equipment used in the experiments 15  
 
Figure 4 TransQ-1GS Ag/AgCl electrodes from Pro-Med 16 
 
Figure 5 The molecule of Benadryl C17H22ClNO 20  
  
Figure 6 The average potential versus time graphs 23 
 
Figure 7 11 hour experiment with NaCl (a), Benadryl (b) and Vaseline 24 
 
Figure 8 Chromatographic Process 27 
 
Figure 9 The components of HPLC instrument 29 
 
Figure 10 Change of solvents A and B during the whole urine analysis 32 
 
Figure 11 The chromatogram of pure Diphenhydramine Hydrochloride 33 
 
Figure 12 Calibration curve report 34 
 
Figure 13 A chromatogram from 5µL urine analysis containing Benadryl 35 
 
Figure 14 A chromatogram from 5µL urine analysis not containing Benadryl 36 
 
   
 
 
 
  
 
      
       
       
      ii 
 
Trans-Dermal Drug Delivery Through Sweat Glands 
 
Vardan Ter-Antonyan 
                                       ABSTRACT     
Although an iontophoretic trans-dermal drug delivery is known as an effective means 
for drug transportation through the human skin, it is not widely used because of the various 
side effects that come to life due to a high applied voltage of up to 80V. 
This study introduces an alternative means of drug transportation through the skin by means 
of sweat gland activation and reduction of an applied voltage to ensure that the iontophoresis 
is safe. The skin conductance studies performed on the pulmar area using 50mM of NaCl 
showed that the activation of sweat glands led to the increase of the skin conductance up to 
8-10 times which enabled us to use a lower voltage of 2V in order to achieve noticeable 
results during the actual drug delivery experiment performed in the points of low ionic 
resistance that are located on a human biceps, also the application of Vaseline on the 
experimental surface does not allow the decrease of a skin conductance for as long as 11 
hours which enables us to do the drug delivery over a long period of time. Finally, the drug 
delivery was performed and tested by means of HPLC method. 
 
 
 
 
      iii  
 
Chapter 1 
Introduction 
Transdermal drug delivery has been a century old discovery, nevertheless, the topic 
still attracts new and revolutionary ideas of researchers everywhere in hope to find the one 
transdermal method that would be efficient, practical, safe, and cheap. One of the leading 
transdermal drug delivery methods out on the market and still in intense research is 
iontophoresis. The technique provides a noninvasive method to administer a controlled 
amount of drugs through the skin by applying an electric current. To simplify its mechanism, 
“Iontophoresis is a process of transportation of ionic molecules into the tissues by passage of 
electric current through the electrolyte solution containing the ionic molecules using a 
suitable electrode polarity, a so called (Needle-less injection)”(Korula, p.1)  
The biggest question is: “Why do we need an Iontophoretic Drug Delivery if we can 
use direct injections or oral pills?" Needle injection of drugs is one of the most invasive 
methods of drug administering, it damages the tissue which may not heal in case of patients 
with diabetes, and in case of careless injection a patient can die from administering tiny 
bubble of air into a vain, infection or inflammation, it also is painful if performed 
improperly, also it is very hard to control the amount of drug administered by an injection 
and can cause an overdose and in some cases death.  
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On the other hand oral administration of drugs is relatively painless but can cause 
gastrointestinal incompatibility for some patients, occurrence of unnecessary metabolisms, as 
well as overdose of drugs occurring due to lack of ability to control the amount of drugs 
taken orally (Secundum Artem, p.2).  
Iontophoretic drug delivery was designed and created to control the amount of drugs 
delivered into a human body through variation of applied voltage, ionic current, drug 
concentration or ionic strength.  
Iontophoresis is the only acceptable and safe choice of drug delivery on the burned 
skin to avoid an infection. It is used in the tooth extraction and treatment of infected tooth 
root canals. It also is the best choice for patients with stomach problems.  Patients with 
diabetes suffer a great deal from injections because their wounds do not heal very well and 
can cause deadly infections and inflammations, which is why scientists started thinking 
about the Iontophoresis as the safest drug delivery method. 
 There are three main passages through the skin’s barrier: the stratum conium, the 
sweat duct, and the hair follicles (Nair, p. 468).The first passage is used by the contemporary 
iontophoresis methods. Although these methods have their advantages, they are not entirely 
safe. Contemporary iontophoresis is carried out using high voltage of up to 80V in order to 
overcome the skin barrier that has a resistance of 5MΩ. Side-effects and reactions like 
itching, erythema, irritation, skin pigmentation, permanent skin diseases, vascular and non-
vascular diseases often occur under the delivery area (Gazelius, pg.2)  
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An alternative method would be to avoid the passage across the stratum conium, by 
utilizing the porous components of the skin such as the sweat ducts and the hair follicles, 
where the resistance is much lower. The passage through hair follicles is not so convenient 
because the channels are very narrow and also hairs prevent the electrodes from sticking to 
the hand and provide a very poor adhesion which is why the trans-dermal iontophoresis is 
performed most of the time on the hairless skin. 
Activating the porous component of the skin one can lower the voltage needed to 
overcome the resistance of the skin, and decrease the area of the electrodes increasing the 
convenience of the drug delivery process and eliminating all the side effects that can occur.  
The areas of the sweat glands and the hair follicles is small comparing to the total 
area of the skin, which is why using these pathways for drug delivery had been ignored, until 
now (Barry p.101). The following work focuses on the efficiency of drug delivery through 
the sweat gland. 
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Chapter 2 
Iontophoresis and Contemporary Iontophoretic Methods 
Iontophoresis is a process which involves increased transport of solute molecules into 
a tissue using an electric current (Secundum Artem, V.10, #4, p.1). Iontophoresis is basically 
a method of making "needle-less injections". Transdermal administration is mostly used for 
drugs requiring a relatively small dosage. It can be passive or active. In passive drug 
delivery, the drug diffuses through the dead cells of the skin, the stratum conium. On the 
other hand the active delivery is related to the ionized source of energy provided to drive the 
drug through the skin and its pores. Sometimes certain chemicals are used to enhance the 
skin before the delivery. In iontophoresis, the external source of energy is a direct electrical 
current. Ions traverse the skin according to the "like charges repel each other and opposite 
charges attract" principle (Secundum Artem, V.10, #4, p.1). 
In practice, a drug solution is placed on an active electrode and that electrode is 
placed somewhere on the hairless skin, the passive electrode is placed close to the active 
electrode which provides an effective ion attraction force, and when an electrical current is 
applied the ions start penetrating the skin. Contemporary iontophoretic devices utilize 
current of up to 16µA, and a DC voltage of up to 80V.  Fig. 1 shows the method of trans-
dermal drug delivery currently used all over the world (Subramony, p.27).  
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In the Fig. 1 you notice that the electrodes are located near each other and the drug is 
getting pushed into the skin which requires a huge voltage and electrical current.  
The delivery system consists of an anode, a reservoir containing the drug, a counter 
electrode, and a battery as the electrical energy source (Fig. 1). Under the application of 
an electrical potential, drug ions (D+) move into the skin while biological anions such as 
Cl- migrate from the body into the donor compartment to maintain electrical neutrality 
(Subramony, p.27).   
 The problem with this approach is in the location of the electrodes. The electrodes 
are located close to each other which means that if the system delivers a certain amount 
of drug into the stratum corneum under the influence of 80V voltage, most of this drug 
drifts from the positive electrode to the negative electrode through the stratum corneum 
without flowing into the epidermis, dermis or sub dermis.  
Some companies claim that their iontophoretic device can deliver up to 50mg of 
drug like lidocaine trans-dermaly into the body judging by the difference in weight of the 
drug solution after and before the delivery, but they do not know how much drug has 
actually been delivered into the blood, which makes their approach very imperfect.   
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Figure 1 A contemporary iontophoretic drug delivery system (Subramony, p.27) 
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Chapter 3 
Human Skin 
Human skin is body’s largest organ. In one square inch of human skin there are 
19 million cells, 625 sweat glands, 90 oil glands, 65 hairs, 19 feet of blood vessels, and 
19,000 sensory cells (Richardson, p.1). The outer layer, the epidermis, consists of rows of 
cells about 12 to 15 deep, and is between 0.07 and 0.12 millimeters thick (about as thick as a 
piece of paper). This top layer is composed mainly of dead cells that are being replaced 
constantly by newer cells (Richardson, p.1). Sometimes when the skin is intensely used the 
epidermis creates extra skin layers and makes the skin thicker which prevents injuries and 
skin damages, for example skin on the soles of feet of people who walk barefoot, and on the 
hands of farmers. The inner layer, or dermis, is a spongy, area that is about one millimeter 
thick, consisting mainly of collagen (a fibrous protein found in the skin) connective tissue 
(Richardson, p.1). The dermis is joined to the epidermis by nerves, blood vessels, hair 
follicles, sebaceous glands, and sweat glands. Sweat glands help to cool the skin and keep 
the body temperature constant (Richardson, p.1).   
The sweat glands are distributed all over human skin, about two million of them all 
together, the purpose of which is to bring water to the surface of the skin where this water is 
vaporized and heat is in this manner withdrawn from the body (Asimov, p.258-259).  
     7 
The water in this case is a sweat or perspiration. A sweat gland consists of a tiny 
coiled tube, the main body of which situated deep in the dermis. The tiny opening on the 
surface is a pore and is just barley visible to the naked eye. When you are working or playing 
hard, and heat production is increased, the sweat glands accelerate their production of 
perspiration which is also true when the temperature is unusually high. Perspiration then 
collects on the body in visible drops and we are conscious of sweating (Asimov, p. 265). 
 As you can see in the Fig. 2, the sweat gland and ductal structure arise in the sub 
dermal portion of the skin, beginning with the sweat gland and ending at the surface of the 
skin resulting in a pore. The gland itself consists of a tightly bound mass of tubule, which is 
supplied with nerve endings and capillary blood vessels (Sato, vol.20, #4). The nerves 
stimulate the gland to produce sweat in the event of a psychological stimulus or 
thermoregulatory process (Sato, vol.20, #4). The blood vessels, which surround the sweat 
gland and ductal portion in the dermis, supply the gland and duct with nutrients for 
functioning, and waste products for excretion (Sato, vol.20, #4). From the gland to the base 
of the epidermis, the duct remains relatively straight. The ductal walls are mostly a few cells 
thick in this region. These cells control absorption of sodium and other nutrients in the pre-
sweat fluid before it travels to the surface of the skin (Fowles, p.362-378). The glands pump 
sodium, Na, into the lower portion of the duct, causing a concentration shift. 
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This shift draws more water into the duct, raising the level of water. Since the cells in 
the ductal wall remove sodium and other substances from the sweat, there is a different 
concentration gradient, that moves the solution up the duct, ultimately forcing it onto the 
surface of the skin (Fowles, p.362-378). 
 Before ending as a pore on the surface of the skin, the duct spirals throughout most 
layers of the epidermis and the entire stratum conium. This spiraling has been attributed to 
obtaining a better thermoregulatory efficiency by increasing the surface area that will absorb 
sweat and lose it to evaporation. This is what allows the body to cool itself in high 
temperatures (Fowles, p.362-378). 
 As water diffuses into the intercellular spaces, it forms narrow channels through 
which certain ions can migrate, allowing for an increase in conductivity through the skin 
when thoroughly saturated. The stratum conium cells are in contact with the solution in the 
duct and a solution that covers the surface of the skin during the experiment and the cells 
that border both regions of water are most likely to be affected first. The process continues 
until all cells are saturated, which leads to the closing of the pore which threatens the 
usefulness of our theory and must be overcome. The solution to this problem is given in the 
next chapter (Boucsein) 
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Figure 2. Human Skin (Sato, vol.20, #4) 
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Chapter 4 
       Method 
 It may seem that because the stratum corneum has a much larger surface area than 
sweat glands and hair follicles, it represents a very convenient pathway for drugs to flow 
from the surface of the skin into the blood vessels, but it also has an enormous resistance to 
anything that it comes across with, which is very important for an existence of a human body 
because the skin is our protective shield against water, toxic chemicals and environment. So 
in order to push drugs through our skin we have to utilize high voltage and current in our 
experiments which is very dangerous as was already pointed out in the previous chapters.  
The method proposed in this work suggests the usage of the sweat glands as the only 
and the most effective passage of the drug into the blood vessels in spite of the fact that the 
sweat glands are very small and have very small surface area. Sweat glands are small, but as 
was mentioned before there are a lot of them (~625/inch2), so by utilizing the sweat ducts, 
we can decrease the resistance of the skin and deliver a significant amount of drugs. We 
found that there are places on a human body where the resistance of the skin is very low, 
(about 500KΩ) and those are so called acupuncture points where lots of nerves come 
together, and those points are the best places for this experiment.  
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To be successful in this experiment the sweat glands must be open to create some 
passage ways. Sweat can be induced by increasing the body temperature by means of 
applying a heating pad to the delivery area, drinking hot tea/water/soup, or by attaching 
some external object like polyethylene to the skin, that way the temperature balance of the 
skin will be violated and the skin will start inducing sweat by itself gradually increasing its 
intensity in order to get rid of the attachment.  The main problem related to the sweat glands 
that we had to overcome was the problem of the sweat gland closure due to the swelling of 
the dead cells of the stratum conium (Fowles p. 365). The sweat glands are prevented from 
closure by applying a thin layer of Vaseline on the surface of the skin in the delivery area. 
When the Vaseline is on the skin the stratum corneum is closed and so are all the pores of the 
skin including the sweat glands. When the experimental area starts sweating, the sweat 
glands start getting full of sweat and under a big pressure from inside the duct, the sweat 
opens holes in the layer of Vaseline and appears on the surface of the Vaseline. The sweat 
then makes its contact with a drug solution in the active electrode, but does not touch the 
skin because of the protective layer of Vaseline, and so this way Vaseline keeps the dead 
cells of the stratum corneum from swelling and closing the sweat pores and the sweat can be 
in contact with the drug solution for a long time until the Vaseline is stripped away.  
By applying Vaseline we have managed to hold a high conductance reading for 11 
hours, this is enough to be convinced that Vaseline partially solves the problems caused by 
pore closure. 
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Chapter 5 
Experimental Set-Up for Skin Conductance Experiments 
 The systematic components of drugs delivery through sweat glands include DC 
power supply, 2 electrodes and an ionic solution Fig.3. Each component must be carefully 
chosen in order to provide an efficient and safe method.  
       A DC power supply of 2V applied to the delivery area gives an average of 4µA, 
which is much safer than 16µA current used in the current iontophoretic methods that utilize 
80V.  The power supply can be provided by a 2V battery for portable and practical usage, 
since the drug delivery period can last up to a few days.  
        The electrodes chosen for the current skin conductance study and the drug delivery 
are the TransQ-1GS electrodes, manufactured by Pro-Med. These Ag/AgCl electrodes 
stabilize the pH of the drug and prevent a shift of pH in a drug or in a tissue (Nair p. 470). 
Prevention of pH shift eliminates possible skin irritation, stabilizes drugs, and improves the 
drug delivery. Ag/AgCl electrodes are also nonpolarizing. This means that the skin and the 
sweat glands do not get polarized and so the development of a counter electromotive force 
(emf) can be prevented (Nair p. 4.70)). Also one of the most important advantages of 
Ag/AgCl electrode is that it has a very low junction potential and also it does not get 
oxidized and consequently does not enter the electrolyte.  
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The electrodes contain a Gel Sponge element which maximizes a uniform skin 
contact, and are the best for longer adhesion to prevent leakage of drug solution. The Gel 
Sponge also provides greater conductivity and consistent current and drug distribution. Also 
the gel makes sure that the drug solution does not make a direct contact with an electrode to 
prevent the electrolyze phenomenon. Fig. 4. 
These electrodes provide an easy and practical way to introduce the drug solution 
into the electrodes. The larger area of the electrodes covers more area of sweat pores which 
maximize the total drug that can be delivered.  
Active electrode on the bottom and Passive electrode on the top. Active electrode 
consists of adhesive tape, Ag/AgCl electrode, conductive gel, and a sponge. Passive 
electrode consists of conductive gel and Ag/AgCl electrode. 
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Figure 3. Schematic diagram of circuit and equipment used in the skin conductance study 
experiments. 
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Figure 4. TransQ-1GS Ag/AgCl electrodes from Pro-Med.  
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Chapter 6 
Skin Conductance Studies 
 As was said previously the schematics of the apparatus used in the skin conductance 
experiment is shown in Fig. 3. It consists of two Silver-Silver Chloride  (Ag-AgCl) 
electrodes, a simple circuit with a data acquisition resistor, a voltage supply, an oscilloscope 
and a computer which records data. When the electrodes are attached to the skin, they form a 
resistor, the resistance of which is measured by placing it in series with a second (much 
smaller) resistor and connecting it to a voltage source. It is the voltage across the smaller 
resistor that is measured via the oscilloscope and recorded into a data file on the computer. 
From the data in this file, the measured voltages can be computed into conductance based on 
the simple relation: 
    
)VV(r
VG
mapp
m
−=                            
which is derived from the Ohm’s law equations, 
)rR(IVapp +=  
 
IrVm =  
 
R/1G =  
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G - represents the conductance of the skin, R – is a resistance of the skin, r – is a 
data acquisition resistor, Vapp  - is the voltage applied to the circuit = 2 V, and Vm – is the 
voltage measured across the data acquisition resistor. During the process of sweating, the 
level of sweat in the duct increases and eventually reaches the surface of the skin, making a 
connection with NaCl solution and completing the circuit. Ones the connection is made, no 
further sweating should be necessary since the sweat in the duct that diffuses into the stratum 
conium is replaced by the unlimited supply provided by the electrode. Because of this, the 
ions can flow through the duct.  
       Factors that affect the drug permeation through stratum conium can be distinguished 
from a simple steady state flux equation for a given thickness of the skin (Eq. (1); Barry, 
1983) 
Φ ~ CDK     
where Φ = dm/dt  is a steady state flux of the drug, C is the drug concentration in donor 
solution, K is the partition coefficient of solute between a skin and the solution, D is the 
diffusion coefficient .  
So factors that affect the drug delivery include the ionized state of the drug, and its 
pH range in which the trans-dermal permission of ionized state is maximum (Korula p.1).  
Other factors including good solubility in oil/water, low melting point (correlating with good 
water solubility), low molecular weight (less than 600 Daltons) (Barry, 1983)   and a high 
concentration of the drug (Korula p. 2).  
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The drug solution chosen for delivery is Benadryl (Diphenhydramine Hydrochloride) 
which is a known antihistamine (see Fig.5). 
This drug has been chosen for delivery because its solubility in water is very high 
( more than 10g in 100mL of water), its molecular weight is relatively low  (~291.8 Daltons), 
and its melting point is also low (~166 Co) (chemfinder.com). 
The chemical formula of Benadryl is (C6H5)2CHOCH2CH2N(CH3)2HCl which is the 
same as C17H22ClNO. Benadryl can only be dissolved in water and it does not enter into a 
reaction. When dissolved in water, the neutral form of Benadryl becomes ionized so we 
observe the following:  C17H22ClNO + H2O => R+ + Cl- which represents a complicated 
organic radical R with charge (+1) and a remaining  non organic acid with charge (-1). This 
is clear because when salts of drugs are dissolved in aqueous solutions, ionized particles are 
formed and this process is called dissociation or ionization  (Secundum Artem, V.10, #4, 
p.3). Now almost all the drugs are available in salt form because of great water solubility, 
and also the formation of ions is a typical behavior for all the water soluble drugs and 
chemicals which have at least one non organic ion, like salts of non organic acids which is 
the case we have. Under the influence of electric field of 2V these ions are transported into 
the skin through the sweat glands and driven into the blood stream. Benadryl can be detected 
easily by the blood or urine test about 8 hours of experiment and it has been delivered 
through the iontophoresis process by many others (Secundum Artem, V.10, #4, p.2).  
Benadryl is also a non-prescription medication that relieves allergy symptoms, 
hypersensitive reactions, motion sickness, and uncontrollable muscle movements. 
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  (a)       (b) 
 
Figure 5. The molecule of Benadryl C17H22ClNO (a) in 3 dimension 
(www.chemistry.org) and (b) in 2 dimension (www.chemfinder.com) 
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Chapter 7 
The Results of the Skin Conductance Studies 
  The results presented in this chapter are the averages of many similar experiments 
carried out at different times of the day and on different days. In order for an experiment to 
be successful, a subject has to sweat in the particular areas of the experiment where the 
electrodes are placed. So ones a subject sweats well enough to activate and open the sweat 
ducts, the potential readings increase significantly. 
In order to make sure that the electric field goes through the sweat glands under the 
positive electrode to the negative electrode through the sweat glands located under it, both 
electrodes were placed facing each other, positive electrode on one side of a biceps and the 
negative electrode on the opposite site, so that the electric field goes straight from the 
positive to the negative electrode, which makes sure that the electric field is traveling 
through the sweat glands and not just through the skin (see Fig. 4).  
The experiments with 50mM of NaCl showed that the conductance of the dry pulmar 
skin was about 7-8 times less than the conductance of the sweating pulmar skin, which 
means that the sweat glands contribute a lot to the conductance of the skin and the activated 
sweat glands increase the conductance enough to deliver drugs. The average results of the 
experiment carried out on a palm is presented in Fig. 6. 
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The “Control” value of the average skin potential is about 3mV and after 30 minutes 
it increases until about 5mV. This increase is due to sweating that is induced due to the 
violation of the temperature balance of the skin after attaching the electrodes to the skin and 
also due to the hydration of the skin when the electrolyte makes contact with the skin.  As 
you can see the potential (therefore the conductance) increased tremendously (with respect to 
the “Control” value) in case of the sweating experimental area. Over the course of 10 
minutes the conductance reached its peak value and stayed there for about 5 minutes, then 
decreased. The decrease of the conductance was due to the closure of the sweat glands. The 
“Sweating with the Vaseline on” experiments were carried out the same way as the previous 
ones, but here the experimental area was covered with Vaseline which prevented the closure 
of the pores. To prove that the pores remain open for a longer period we did 11 hour 
experiments on the biceps skin in the points of low ionic resistance (~0.5MΩ) and the 
conductance was still holding high. One of the results is shown in Fig. 7(a). It clearly shows 
that that Vaseline is very efficient in preventing pores closure and holding a high 
conductance.  
Fig. 7(b). shows the same experiment but with Diphenhydramine HCl instead of the 
NaCl drug solution. As you can see from Fig. 6 it is clear that the conductance of a palmar 
skin increase about 7-8 times when we use NaCl, activate sweat glands and use Vaseline to 
eliminate the stratum corneum, and from Fig. 7(a) it is clear that by doin the same 
experiment in the points of low resistance on a biceps we get even bigger values for the 
conductance of the skin and again increase the conductance about 7-8 times.  
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Figure 6. The average potential versus time graphs for the “Control” (dry skin-pink line), 
“Sweating”(red line) and “Sweating with the Vaseline on” (blue line) experiments carried 
out on a palm. 
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Figure 7(a).  “11 hour” experiment on the biceps with Vaseline (blue line) and about 2 
hours experiment without Vaseline (pink line), (b) 11 hour experiment on the biceps with 
Vaseline using Diphenhydramine HCl.  
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Chapter 8 
High Performance Liquid Chromatograph (HPLC) as a Separator 
The purpose of this chapter is to introduce the theoretical aspects of chromatography. 
In chromatography, a liquid sample is applied to a narrow cross section of a column which is 
filled with a sand-like Silica based material composed primarily of Carbon chains .  A 
solvent is pumped through the column, sweeping the sample from the inlet to the outlet and 
through a detector.  It is the differential interaction of the various components in the sample 
with the stationary phase of the packing material which effects the separation.  This is shown 
in Fig. 8, where a mixture of the molecules, A and C, have been injected into a narrow zone 
at the inlet of the column (Beckman, p.1). While moving with the solvent (mobile phase),  A 
and C become slightly separated because C shows a greater affinity for the stationary phase 
and moves more slowly than A.  Eventually A elutes, distinct from and followed by C - this 
separation is the goal of the chromatography (Beckman, p.1). A chromatogram is a two 
dimensional plot of molecules eluting from a column; measurement of absorbance or some 
other defining property is plotted against elution time or volume. In HPLC, the mobile phase 
is a liquid and the stationary phase is usually a coating bonded to a small solid particle, 
called a support, which is contained in a metal cylinder or column.  A molecule is retained if 
it partitions into the stationary phase rather than merely traveling with the mobile phase 
(Beckman, p.1).   
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 There are two kinds of chromatography: “Reversed Phase Chromatography (RPC)” 
and “Normal Phase Chromatography (NPC)”. In reverse phase chromatography, the packing 
is nonpolar and the solvent is polar with respect to the sample. Retention is the result of the 
interaction of the nonpolar components of the solutes and the nonpolar stationary phase. On 
the other hand in the normal phase chromatography, the packing is polar and the solvent is 
nonpolar with respect to the sample.  
 Typical stationary phases are nonpolar hydrocarbons, waxy liquids or bonded 
hydrocarbons (such as C18, C8, C4, etc.) and the solvents are polar aqueous-organic mixtures 
such as methanol-water, acetonitrile-water, or phosphoric acid-water   (Beckman, p.1). The 
C18, C8, and phenyl bonded phases are most often used in the reverse phase mode and it has 
been estimated that 60-90% of all analytical LC separations are done on bonded phases in 
the reverse phase mode (Beckman, p.1). Bonded phases made by covalently bonding a 
molecule onto a solid stationary phase are intended to prepare "liquid coatings" which will 
be permanent. Silica is a reactive substrate to which various functionalities can be attached 
or bonded. The functionalities most widely bonded to silica are the alkyl (C18 and C8), 
aromatic phenyl, and cyano and amino groups (Beckman, p.1). 
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 Figure 8. Chromatographic Process  
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8.1. Instrumentation 
 Fig. 9 presents a block diagram showing the components of an HPLC instrument. 
Solvents are pumped into a Solvent Delivery System where they are mixed together and 
passed through a Degasser and Debubbler to get rid of gasses and bubbles inside of the 
solvents. After that, the mixture of solvents is pumped to the injection port where the sample 
is injected into the (HPLC) instrument. The solvents mix with the sample and the whole 
solution is passed through the column. In the column the chemicals are retained and one after 
another they flow to the detector which is a UV-Vis Spectrophotometer most of the time. 
UV-Vis provides the peaks as the signals received from each individual chemical. 
 
8.2. HPLC Analysis 
 The first and the most important part in HPLC analysis is the development of a 
method by which the sample is going to be analyzed. The method contains such important 
information as the flow rate of the solution through the column, the wavelength of detection 
of a specific chemical of interest, the temperature of the environment inside the instrument, 
the solvents that are used and their proportion at each moment of time during the experiment, 
the duration of the whole experiment, the name of the chemical of interest, and many more 
parameters which have to be set before starting the experiment itself. Each and every 
parameter mentioned above can change the result dramatically. When the peak retention time 
of the pure chemical of interest is found, the method can be considered successful and the 
real experiment can be done. 
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 After finding the method the calibration should be performed and a calibration curve 
should be obtained in order to determine the amount of the chemical of interest in a sample. 
After this is all done, the sample should pass through the Solid Phase Extraction (SPE) 
process. Here the sample is passed through a special pre-treated and moisturized cartridges 
that contain material similar to the bedding material of the column itself. This process 
eliminates most of the contaminants and big particles in the sample so that it is ready to be 
injected into the HPLC instrument. 
 When the final chromatogram is on the screen, the peak of the chemical of 
interest is already visualized among the rest of the peaks in the sample and the peak area 
is presented. This peak area is the key to find the amount of a specific chemical in the 
sample. 
 
       
 
Figure 9. The components of HPLC instrument and the instrument itself. 
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Chapter 9 
The Results of the Drug Delivery Experiment 
 Finally we performed a trans-dermal drug delivery on the biceps skin of a subject  for 
8 hours and collected the urine to determine the amount of Diphenhydramine Hydrochloride 
in it. That urine was then worked up under the solid phase extraction process. SPE process 
eliminates all kinds of contaminants and big particles from the urine so that they don’t 
prevent us from getting the final urine analysis by means of a special High Performance 
Liquid Chromatograph. The HPLC method that has been used to separate the 
Diphenhydramine Hydrochloride was carefully chosen to get the best separation. 
Column: ZORBAX Rx/SB-C8 (4.6 x 150 mm), Solvent A: 20mM of KH2PO4  Phosphoric 
Acid, Solvent B: 10% Acetonitrile (60/40), Flow rate: 2mL/min, Temperature: 25oC,  
Detector: UV at λ = 254 nm. 
 Fig. 10 presents the change of solvents A and B during the whole separation process 
that leaded to the best separation of Diphenhydramine HCl peak from the rest of the 
chemicals in the urine. The first experiment was done just on the pure sample of 1mg of 
Diphenhydramine HCl in 100mL of HPLC grade water to find out the retention time of the 
drug. The result is presented in Fig. 11. This chromatogram shows us that the retention time 
of Diphenhydramine Hydrochloride is tR=3.655± 0.02 minutes. After that we performed 5 
consequent experiments at 10µL, 8µL, 6µL, 4µL, and 2µL injection volumes for calibration 
purposes. 
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The constructed calibration curve is presented on the Fig. 12. Each experiment was 
repeated a few times to determine the measurement errors which you can see on the curve. 
The X and Y errors are presented as bars around the points.  
 After the calibration curve was constructed we performed the drug delivery 
on the same subject for 8 hours. After the urine was collected it was passed through 
the solid phase extraction process and 5µL of it was passed though the HPLC instrument 
using the same method mentioned above. The result is shown in the Fig. 13. 
 On Fig. 13 you can clearly see the peak of Diphenhydramine HCl having an area of 
0.255 Volts*sec. This point is represented on the calibration curve as a big square having a 
peak size of 0.255 V*sec and the amount of 2.92µL. Consequently for 1µL injection volume 
we will get a peak having an area of 0.055 V*sec and the amount of 0.584µL. 
This point is presented on the calibration curve as a big triangle. 
Each round point on the calibration curve represent experimental data obtained from HPLC 
instrument after analysis of 1mg of pure  Diphenhydramine HCl in the 100mL of HPLC 
grade water along with the measurement errors. The big square represents the 
Diphenhydramine HCl peak with its parameters (amount and peak size), obtained from 5µL 
urine injection volume after the drug delivery. The big triangle represents the same but from 
1µL urine injection volume. Also you can see the R2 coefficient and the calibration function. 
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We also have performed an analysis of a regular urine without Diphenhydramine 
Hydrochloride inside to determine whether the found peak is the peak that we are looking 
for, or a regular fluctuation. As you can see from the Fig. 14, we found no evidence of any 
sort of Diphenhydramine peak which shows that our results are very reliable because the 
area under the Diphenhydramine peak is much more than the measurement error which is 
about 4% .   
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Figure 10 Change of the amount of solvents A and B during the whole urine analysis. 
 Solvent A: 20mM of KH2PO4 Phosphoric Acid. 
 Solvent B: 10% Acetonitrile in the HPLC grade water. 
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Figure 11 . The chromatogram of 1mg of pure Diphenhydramine Hydrochloride in 
100mL of HPLC grade water. 
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Figure 12. Calibration curve report. 
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Figure 13. A chromatogram from urine analysis of a subject who was under 8 hour drug 
delivery experiment. 
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Figure 14 The HPLC analysis of pure urine without Benadryl. 
 
 
 
 
 
 
 
36 
 
9.1. Results 
 The data analysis shows that we found about 6± 0.24ng of Diphenhydramine 
Hydrochloride in 1µL of injected urine that was obtained from 8 hours of experiment. 
The average amount of urine after the experiment is about 300mL so we find about 1.8mg of 
Diphenhydramine Hydrochloride in the urine after 8 hours of experiment.  All of these 
experiments were reproduced taking into account the measurement errors. The drug delivery 
experiments without Vaseline showed about 3 times smaller results, and the diffusion 
experiments without Vaseline and electric field showed about 4 times smaller results.  
 As specified in (WebMD Health Source) Diphenhydramine is widely distributed 
throughout the body, including the CNS. Little amount, is excreted unchanged in the urine 
and most appears as the degradation products of metabolic transformation in the liver, which 
are almost completely excreted within 24 hours, and according to this, there is a lot more 
Diphenhydramine Hydrochloride in the whole body than is found in the urine. When a drug 
is taken orally it passes through lots of organs before it reaches the blood vessels and so it is 
lost in the digestion process, and many other places. This means that only some small 
amount of drug goes into the blood and even smaller amount goes into the urine. As 
indicated in the (Ohtsuji M.) the maximum amount of drug found in the urine is about 2% of 
the drug amount taken orally and is about 1% of the drug amount taken through the diffusion 
processes (trans-dermal patch or cream) because most of the drug is broken down and lost in 
the process of getting into the blood and even after that before it gets into the urine. 
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On the other hand I.V. and iontophoresis are more efficient ways of drug administrations 
because most of the drug goes into the blood right away and that is why the oral does is 
twice as much as the I.V. or iontophoresis dose. And so it was experimentally established 
and confirmed that only about 4% of Benadryl taken by an I.V. injection or iontophoresis is 
found in the urine (Chaya Venkat). That means that we deliver about 45mg of Benadryl in 8 
hours of drug delivery. The maximum Diphenhydramine HCl injection dose for adults is 
75mg/day which means that we can deliver this dose by doing 13 hour experiment. The 
minimum injection dose for adults is 12.5mg/day, and we can deliver that in only 2 hours. 
For children the maximum injection dose is about 37.5mg which we can deliver in 6.5 hours 
and minimum injection dose is about 6.25mg which we can deliver in just 1 hour of drug 
delivery.  
 
9.2. Conclusion 
The new method of the sweat gland activation enables us to overcome the skin 
resistance. The swelling of the stratum cornium is prevented by applying a thin layer of thick 
Vaseline to the skin.  We can deliver the minimum Benadryl injection dose in 2 hours for 
adults and 1 hour for children (6-12 years old) and we can deliver the maximum Benadryl 
dose in 13 hours for adults and twice faster for children. Our drug delivery method is much 
safer than the methods that are used all over the world, which is why this method provides a 
foundation to deliver drugs more safely and efficiently without any possible side effects.   
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